Get started
Author

William Laband

ORCID: 0009-0006-5744-5635
Observed ORCID: 0009-0006-5744-5635
OpenAlex ID: A5078880715
COVID-19 infection causing residual gastrointestinal symptoms – a single UK centre case series
2022 · Joseph Cooney, Priscilla Appiahene, et al. · Clinical Medicine · 28
PDF
Sex Differences in the Prescription of P2Y12 Inhibitor Agents Following Percutaneous Coronary Intervention
2025 · Surik Sedrakyan, William Laband, et al. · Catheterization and Cardiovascular Interventions · 1
Breathless Beats: Unmasking Acute Amiodarone Induced Pneumonitis
2024 · William Laband, Adhiraj Bhattacharya, et al. · Journal of the American College of Cardiology · 1
Abstract 14161: Recreational Cannabis Use and the Risk of Atrial Arrhythmias: Evidence From a Meta-Analysis of Observational Studies
2023 · Levindo Jose Garcia Quarto, Thalys Sampaio Rodrigues, et al. · Circulation · 1
26-ccc-10419-acc Methicillin Susceptible Staphylococcus Aureus (mssa) Pericardial Effusion Complicated by Coronary Aneurysms
2026 · Sherry Zhang, William Laband, et al. · Journal of the American College of Cardiology
The Effect of Insurance Type on the Selection of Antiplatelet Therapy After Percutaneous Coronary Intervention
2025 · Surik Sedrakyan, William Laband, et al. · Journal of the American College of Cardiology
PDF
Abstract 4122590: Sex Differences in the Prescription of P2Y12 Inhibitor Agents Following Percutaneous Coronary Intervention
2024 · William Laband, Surik Sedrakyan, et al. · Circulation
Abstract 4140140: Cardiology Follow-Up as a Determinant of LDL-C Management Success in Secondary Cardiovascular Prevention
2024 · Surik Sedrakyan, William Laband, et al. · Circulation
Incorporating multiple biomarkers to assess mortality risk in non‐ST elevation myocardial infarction
2024 · William Laband, Igor Vaz · Clinical Cardiology
Works count: 9
Citation count: 31
H-index: 1
I10-index: 1
Year
Topic
Type